coronavirus vaccine with United States regulators Friday, days after the company said it finished its final round of human trials — with promising results.Pfizer and its partner company, BioNTech, said the final data shows its vaccine is 95 per cent effective against the virus, with no serious safety concerns.
But, the full results of its trial have not been released and must be peer-reviewed by independents scientists. Pfizer applies for emergency coronavirus vaccine approval in U.S.
Read more on globalnews.ca